New! View global litigation for patent families

US20060019328A1 - Glucose dehydrogenase - Google Patents

Glucose dehydrogenase Download PDF

Info

Publication number
US20060019328A1
US20060019328A1 US11184834 US18483405A US20060019328A1 US 20060019328 A1 US20060019328 A1 US 20060019328A1 US 11184834 US11184834 US 11184834 US 18483405 A US18483405 A US 18483405A US 20060019328 A1 US20060019328 A1 US 20060019328A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
glucose
modified
acid
amino
pqqgdh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11184834
Inventor
Koji Sode
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ultizyme International Ltd
Sode Koji
Original Assignee
Koji Sode
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)

Abstract

Modified water-soluble glucose dehydrogenases having pyrrolo-quinoline quinone as a coenzyme are provided wherein at least one amino acid residue is replaced by another amino acid residue in a specific region. Modified water-soluble PQQGDHs of the present invention have improved affinity for glucose.

Description

    TECHNICAL FIELD
  • [0001]
    The present invention relates to the preparation of glucose dehydrogenases having pyrrolo-quinoline quinone as a coenzyme (PQQGDH) and their use for glucose assays.
  • BACKGROUND ART
  • [0002]
    Blood glucose is an important marker for diabetes. In the fermentative production using microorganisms, glucose levels are assayed for monitoring the process. Conventional glucose assays were based on enzymatic methods using a glucose oxidase (GOD) or glucose-6-phosphate dehydrogenase (G6PDH). However, GOD-based assays required addition of a catalase or peroxidase to the assay system in order to quantitate the hydrogen peroxide generated by glucose oxidation reaction. G6PDHs have been used for spectrophotometric glucose assays, in which case a coenzyme NAD(P) had to be added to the reaction system.
  • [0003]
    Accordingly, an object of the present invention is to provide a modified water-soluble PQQGDH with improved affinity for glucose. Another object of the present invention is to provide a modified water-soluble PQQGDH with high selectivity for glucose in order to increase the sensitivity for measuring blood glucose levels.
  • DISCLOSURE OF THE INVENTION
  • [0004]
    We found that PQQGDHs with high affinity for glucose are useful as novel enzymes alternative to the enzymes that have been used for enzymatic glucose assays.
  • [0005]
    PQQGDHs are glucose dehydrogenases having pyrroloquinoline quinone as a coenzyme, which catalyze the reaction in which glucose is oxidized to produce gluconolactone.
  • [0006]
    PQQGDHs are known to include membrane-bound enzymes and water-soluble enzymes. Membrane-bound PQQGDHs are single peptide proteins having a molecular weight of about 87 kDa and widely found in various gram-negative bacteria. For example, see A M. Cleton-Jansen et al., J. Bacteriol. (1990) 172, 6308-6315. On the other hand, water-soluble PQQGDHs have been identified in several strains of Acinetobacter calcoaceticus (Biosci. Biotech. Biochem. (1995), 59(8), 1548-1555), and their structural genes were cloned to show the amino acid sequences (Mol. Gen. Genet. (1989), 217:430-436). The water-soluble PQQGDH derived from A. calcoaceticus is a homodimer having a molecular weight of about 50 kDa. It has little homology in primary structure of protein with other PQQ enzymes.
  • [0007]
    Recently, the results of an X-ray crystal structure analysis of this enzyme were reported to show the higher-order structure of the enzyme including the active center (J. Mol. Biol., 289, 319-333 (1999), The crystal structure of the apo form of the soluble quinoprotein glucose dehydrogenase from Acinetobacter calcoaceticus reveals a novel internal conserved sequence repeat; A. Oubrie et al., The EMBO Journal, 18(19) 5187-5194 (1999), Structure and mechanism of soluble quinoprotein glucose dehydrogenase, A. Oubrie et al., PNAS, 96(21), 11787-11791 (1999), Active-site structure of the soluble quinoprotein glucose dehydrogenase complexed with methylhydrazine; A covalent cofactor-inhibitor complex, A. Oubrie et al.). These papers showed that the water-soluble PQQGDH is a β-propeller protein composed of six W-motifs.
  • [0008]
    As a result of careful studies to develop a modified PQQGDH that can be applied to clinical tests or food analyses by improving the conventional water-soluble PQQGDH to increase the affinity for glucose, we succeeded in obtaining an enzyme with high affinity for glucose by introducing an amino acid change into a specific region of the water-soluble PQQGDH.
  • [0009]
    Accordingly, the present invention provides a modified water-soluble glucose dehydrogenase having pyrroloquinoline quinone as a coenzyme characterized in that at least one amino acid residue in a natural water-soluble glucose dehydrogenase is replaced by another amino acid residue and it has improved affinity for glucose as compared with the natural water-soluble glucose dehydrogenase. The modified PQQGDH of the present invention has a Km value for glucose lower than the Km value of the natural PQQGDH, preferably less than 20 mM, more preferably less than 10 mM.
  • [0010]
    Preferably, the modified glucose dehydrogenase of the present invention has increased affinity for glucose though its affinities for other sugars are unchanged or decreased, whereby it has higher selectivity for glucose than the natural water-soluble glucose dehydrogenase. Especially, the reactivity against lactose or maltose is decreased from that of the wild-type in contrast to the reactivity to glucose. When the reactivity against glucose is supposed to be 100%, the activity to lactose or maltose is preferably 60% or less, more preferably 50% or less, still more preferably 40% or less.
  • [0011]
    In an embodiment of the PQQ glucose dehydrogenase of the present invention, at least one amino acid residue in the region corresponding to residues 268-289 or 448-468 in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus is replaced by another amino acid residue, i.e. an amino acid residue other than the relevant amino acid residue in the natural PQQ glucose dehydrogenase. The amino acid numbering herein starts from the initiator methionine as the +1 position.
  • [0012]
    The term “correspond to” used herein with reference to amino acid residues or regions means that some amino acid residues or regions have an equivalent function in two or more structurally similar but distinct proteins. For example, any region in water-soluble PQQGDHs derived from other organisms than Acinetobacter calcoaceticus is said to “correspond to the region defined by residues 268-289 in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus” if this region has a high similarity in the amino acid sequence to the region defined by residues 268-289 in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus and this region is reasonably considered from the secondary structure of the protein to have the same function in that protein. In addition, the 10th amino acid residue in this region is said to “correspond to the 277th residue in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus”.
  • [0013]
    In preferred modified PQQGDHs of the present invention, at least one amino acid residue corresponding to glutamate 277, isoleucine 278, asparagine 462, asparagine 452, lysine 455, aspartate 456, aspartate 457 or aspartate 448 in the amino acid sequence shown as SEQ ID NO: 1 is replaced by another amino acid residue.
  • [0014]
    In more preferred modified PQQGDHs of the present invention, glutamate 277 is replaced by an amino acid residue selected from the group consisting of alanine, asparagine, lysine, aspartate, histidine, glutamine, valine and glycine, or isoleucine 278 is replaced by phenylalanine in the amino acid sequence shown as SEQ ID NO: 1.
  • [0015]
    In another aspect, modified PQQGDHs of the present invention comprise the sequence:
    • Xaa8 Thr Ala Gly Xaa1 Val Gln Xaa2 Xaa3 Xaa4 Gly Ser Val Thr Xaa5 Thr Leu Glu Asn Pro Gly
      wherein Xaa1, Xaa2, Xaa3, Xaa4, Xaa5 and Xaa8 represent any natural amino acid residue, provided that when Xaa1 represents Asn, Xaa2 represents Lys, Xaa3 represents Asp, Xaa4 represents Asp and Xaa5 represents Asn, then Xaa8 does not represent Asp.
  • [0017]
    In another aspect, modified PQQGDHs of the present invention comprise the sequence:
    • Ser Glu Gln Gly Pro Asn Ser Asp Asp Xaa6 Xaa7 Asn Leu Ile Val Lys Gly Gly Asn Tyr Gly Trp
      wherein Xaa6 and Xaa7 represent any natural amino acid residue, provided that when Xaa6 represents Glu, Xaa7 does not represent Ile.
  • [0019]
    The present invention also provides a gene encoding any of the modified glucose dehydrogenases described above, a vector containing said gene and a transformant containing said gene, as well as a glucose assay kit and a glucose sensor comprising a modified glucose dehydrogenase of the present invention.
  • [0020]
    Enzyme proteins of modified PQQGDHs of the present invention have high affinity for glucose and high oxidation activity for glucose so that they can be applied to highly sensitive and highly selective glucose assays.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0021]
    FIG. 1 shows the structure of the plasmid pGB2 used in the present invention.
  • [0022]
    FIG. 2 shows a scheme for preparing a mutant gene encoding a modified enzyme of the present invention.
  • [0023]
    FIG. 3 shows a glucose assay using a modified PQQGDH of the present invention.
  • THE MOST PREFERRED EMBODIMENTS OF THE INVENTION
  • [0000]
    Structure of Modified POOGDHs
  • [0024]
    We introduced random mutations into the coding region of the gene encoding the water-soluble PQQGDH by error-prone PCR to construct a library of water-soluble PQQGDHs carrying amino acid changes. These genes were transformed into E. Coli and screened for the activity of the PQQGDHs against glucose to give a number of clones that express PQQGDHs having comparable activities for 20 mM glucose and 100 mM glucose and improved reactivity against low-level glucose as compared with that of the wild-type enzyme.
  • [0025]
    Analysis of the nucleotide sequence of one of these clones showed that Glu 277 had been changed to Gly. When this amino acid residue was replaced by various other amino acid residues, excellent mutant enzymes with improved affinity for glucose as compared with that of the wild type water-soluble PQQGDH were obtained in every case.
  • [0026]
    Then, site-specific mutations were introduced into other residues near the 277th residue and the affinity for glucose was determined. Modified enzymes carrying Ile278Phe and Asn279His in the region defiend by residues 268-289 were prepared and assayed for the activity to show that these modified enzymes had high affinity for glucose.
  • [0027]
    A number of clones obtained as above were further screened for clones that express PQQGDHs having activity for 20 mM glucose comparable to that of the wild-type PQQGDH but activity for 20 mM lactose lower than that of the wild-type PQQGDH.
  • [0028]
    Analysis of the nucleotide sequence of one of these clones showed that Asn 452 had been changed to Asp. When this residue was replaced by threonine, lysine, isoleucine, histidine or aspartate, excellent mutant enzymes with improved selectivity for glucose as compared with that of the wild type water-soluble PQQGDH were obtained in every case. Mutations were also introduced into other residues near the 452nd residue in the same manner. Mutant enzymes carrying Lys455Ile, Asp456Asn, Asp457Asn, Asn462Asp, Asp448Asn were constructed. As a result, all the mutant enzymes were found to have improved selectivity for glucose as shown in Table 4.
  • [0029]
    In preferred PQQ glucose dehydrogenases of the present invention, at least one amino acid residue is replaced by another amino acid residue in the region corresponding to residues 448-468 in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus. In preferred modified PQQGDHs of the present invention, at least one amino acid residue corresponding to asparagine 462, lysine 452, aspartate 456, aspartate 457 or aspartate 448 in the amino acid sequence shown as SEQ ID NO: 1 is replaced by another amino acid residue.
  • [0030]
    In another aspect, modified PQQGDHs of the present invention comprise the sequence:
    • Xaa8 Thr Ala Gly Xaa1 Val Gln Xaa2 Xaa3 Xaa4 Gly Ser Val Thr Xaa5 Thr Leu Glu Asn Pro Gly
      wherein Xaa1, Xaa2, Xaa3, Xaa4, Xaa5 and Xaa8 represent any natural amino acid residue, provided that when Xaa1 represents Asn, Xaa2 represents Lys, Xaa3 represents Asp, Xaa4 represents Asp and Xaa5 represents Asn, then Xaa8 does not represent Asp.
  • [0032]
    In other preferred PQQ glucose dehydrogenases of the present invention, at least one amino acid residue is replaced by another amino acid residue in the region corresponding to residues 268-289 in the amino acid sequence shown as SEQ ID NO: 1. In especially preferred modified PQQGDHs of the present invention, glutamate 277 is replaced by an amino acid residue selected from the group consisting of alanine, asparagine, lysine, aspartate, histidine, glutamine, valine and glycine, or isoleucine 278 is replaced by phenylalanine in the amino acid sequence shown as SEQ ID NO: 1.
  • [0033]
    In another aspect, modified PQQGDHs of the present invention comprise the sequence:
    • Ser Glu Gln Gly Pro Asn Ser Asp Asp Xaa6 Xaa7 Asn Leu Ile Val Lys Gly Gly Asn Tyr Gly Trp
      wherein Xaa6 and Xaa7 represent any natural amino acid residue, provided that when Xaa6 represents Glu, Xaa7 does not represent Ile.
  • [0035]
    In modified glucose dehydrogenases of the present invention, other amino acid residues may be partially deleted or substituted or other amino acid residues may be added so far as glucose dehydrogenase activity is retained.
  • [0036]
    Those skilled in the art can also replace an amino acid residue in water-soluble PQQGDHs derived from other bacteria according to the teaching herein to obtain modified glucose dehydrogenases with improved affinity for glucose. Particularly, amino acid residues corresponding to glutamate 277, isoleucine 278, asparagine 462, lysine 452, aspartate 455, aspartate 456, aspartate 457 and aspartate 448 in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus can be readily identified by comparing the primary structures of proteins in alignment or comparing the secondary structures predicted from the primary structures of the enzymes. Modified glucose dehydrogenases with improved affinity for substrate can be obtained by replacing such amino acid residues according to the present invention. These modified glucose dehydrogenases are also within the scope of the present invention.
  • [0000]
    Process for Preparing Modified PQQGDHs
  • [0037]
    The sequence of the gene encoding the wild-type water-soluble PQQGDH derived from Acinetobacter calcoaceticus is defined by SEQ ID NO: 2.
  • [0038]
    Genes encoding modified PQQGDHs of the present invention can be constructed by replacing the nucleotide sequence encoding a specific amino acid residue in the gene encoding the wild-type water-soluble PQQGDH by the nucleotide sequence encoding an amino acid residue to be substituted. Various techniques for such site-specific nucleotide sequence substitution are known in the art as described in Sambrook et al., “Molecular Cloning: A Laboratory Manual”, Second Edition, 1989, Cold Spring Harbor Laboratory Press, New York, for example.
  • [0039]
    Thus obtained mutant gene is inserted into a gene expression vector (for example, a plasmid) and transformed into an appropriate host (for example, E. coli). A number of vector/host systems for expressing a foreign protein are known and various hosts such as bacteria, yeasts or cultured cells are suitable.
  • [0040]
    Random mutations are introduced by error-prone PCR into a target region to construct a gene library of modified water-soluble PQQGDHs carrying mutations in the target region. These genes are transformed into E. coli to screen each clone for the affinity of the PQQGDH for glucose. Water-soluble PQQGDHs are secreted into the periplasmic space when they are expressed in E. coli, so that they can be easily assayed for enzyme activity using the E. coli cells. This library is combined with a PMS-DCIP dye in the presence of 20 mM glucose to visually determine the PQQGDH activity so that clones showing activity comparable to the activity for 100 mM glucose are selected and analyzed for the nucleotide sequence to confirm the mutation.
  • [0041]
    In order to obtain modified PQQGDHs with improved selectivity for glucose, this library is combined with a PMS-DCIP dye to visually determine the PQQGDH activity so that clones showing activity for 20 mM glucose comparable to that of the wild-type PQQGDH but activity for 20 mM lactose lower than that of the wild-type PQQGDH are selected and analyzed for the nucleotide sequence to confirm the mutation.
  • [0042]
    Thus obtained transformed cells expressing modified PQQGDHs are cultured and harvested by centrifugation or other means from the culture medium, and then disrupted with a French press or osmotically shocked to release the periplasmic enzyme into the medium. The enzyme may be ultracentrifuged to give a water-soluble PQQGDH-containing fraction. Alternatively, the expressed PQQGDH may be secreted into the medium by using an appropriate host/vector system. The resulting water-soluble fraction is purified by ion exchange chromatography, affinity chromatography, HPLC and the like to prepare a modified PQQGDH of the present invention.
  • [0000]
    Method for Assaying Enzyme Activity
  • [0043]
    PQQGDHs of the present invention associate with PQQ as a coenzyme in catalyzing the reaction in which glucose is oxidized to produce gluconolactone.
  • [0044]
    The enzyme activity can be assayed by using the color-developing reaction of a redox dye to measure the amount of PQQ reduced with PQQGDH-catalyzed oxidation of glucose. Suitable color-developing reagents include PMS (phenazine methosulfate)-DCIP (2,6-dichlorophenolindophenol), potassium ferricyanide and ferrocene, for example.
  • [0000]
    Affinity for Glucose
  • [0045]
    Modified PQQGDHs of the present invention have greatly improved affinity for glucose as compared with that of the wild type. Thus, modified PQQGDHs have a Km value for glucose that is greatly lower than the Km value for glucose of the wild-type PQQGDH. Among modified PQQGDHs, the Glu277Lys variant has a Km value for glucose of 8.8 mM and a maximum activity comparable to that of the wild-type enzyme so that it has improved reactivity against glucose at low levels.
  • [0046]
    Therefore, assay kits or enzyme sensors prepared with modified enzymes of the present invention have the excellent advantages that they can detect glucose at low levels because of the high sensitivity for glucose assays.
  • [0000]
    Evaluation Method of Selectivity
  • [0047]
    Selectivity for glucose of PQQGDHs of the present invention can be evaluated by assaying the enzyme activity as described above using various sugars such as 2-deoxy-D-glucose, mannose, allose, 3-o-methyl-D-glucose, galactose, xylose, lactose and maltose as substrates and determining the relative activity to the activity for glucose.
  • [0000]
    Glucose Assay Kit
  • [0048]
    The present invention also relates to a glucose assay kit comprising a modified PQQGDH according to the present invention. The glucose assay kit of the present invention comprises a modified PQQGDH according to the present invention in an amount enough for at least one run of assay. In addition to the modified PQQGDH according to the present invention, the kit typically comprises a necessary buffer for the assay, a mediator, standard glucose solutions for preparing a calibration curve and instructions. Modified PQQGDHs according to the present invention can be provided in various forms such as freeze-dried reagents or solutions in appropriate preservative solutions. Modified PQQGDHs according to the present invention are preferably provided in the form of a holoenzyme, though they may also be provided as an apoenzyme and converted into a holoenzyme before use.
  • [0000]
    Glucose Sensor
  • [0049]
    The present invention also relates to a glucose sensor using a modified PQQGDH according to the present invention. Suitable electrodes include carbon, gold, platinum and the like electrodes, on which an enzyme of the present invention is immobilized by using a crosslinking agent; encapsulation in a polymer matrix; coating with a dialysis membrane; using a photo-crosslinkable polymer, an electrically conductive polymer or a redox polymer; fixing the enzyme in a polymer or adsorbing it onto the electrode with an electron mediator including ferrocene or its derivatives; or any combination thereof. Modified PQQGDHs of the present invention are preferably immobilized in the form of a holoenzyme on an electrode, though they may be immobilized as an apoenzyme and PQQ may be provided as a separate layer or in a solution. Typically, modified PQQGDHs of the present invention are immobilized on a carbon electrode with glutaraldehyde and then treated with an amine-containing reagent to block glutaraldehyde.
  • [0050]
    Glucose levels can be measured as follows. PQQ, CaCl2 and a mediator are added to a thermostat cell containing a buffer and kept at a constant temperature. Suitable mediators include, for example, potassium ferricyanide and phenazine methosulfate. An electrode on which a modified PQQGDH of the present invention has been immobilized is used as a working electrode in combination with a counter electrode (e.g. a platinum electrode) and a reference electrode (e.g. an Ag/AgCl electrode). After a constant voltage is applied to the carbon electrode to reach a steady current, a glucose-containing sample is added to measure the increase in current. The glucose level in the sample can be calculated from a calibration curve prepared with glucose solutions at standard concentrations.
  • [0051]
    The disclosures of all the patents and documents cited herein are entirely incorporated herein as reference. The present application claims priority based on Japanese Patent Applications Nos. 1999-124285 and 2000-9137, the disclosure of which is entirely incorporated herein as reference.
  • [0052]
    The following examples further illustrate the present invention without, however, limiting the same thereto.
  • EXAMPLE 1
  • [0000]
    Construction and Screening of a Mutant PQQGDH Gene Library:
  • [0053]
    The plasmid pGB2 was obtained by inserting the structural gene encoding the PQQGDH derived from Acinetobacter calcoaceticus into the multicloning site of the vector pTrc99A (Pharmacia) (FIG. 1). This plasmid was used as a template to introduce random mutations into various regions by error-prone PCR. The PCR reaction was carried out in a solution having the composition shown in Table 1 under the conditions of 94° C. for 3 minutes, 30 cycles of 94° C. for 3 minutes, 50° C. for 2 minutes and 72° C. for 2 minutes, and finally 72° C. for 10 minutes.
    TABLE 1
    TaqDNA polymerase (5 U/μl) 0.5 μl
    Template DNA 1.0 μl
    Forward primer ABF 4.0 μl
    Reverse primer ABR 4.0 μl
    10× Taq polymerase buffer 10.0 μl
     1 M β-mercaptoethanol 1.0 μl
    DMSO 10.0 μl
     5 mM MnCl2 10.0 μl
    10 mM dGTP 2.0 μl
     2 mM dATP 2.0 μl
    10 mM dCTP 2.0 μl
    10 mM dTTP 2.0 μl
    H2O 51.5 μl
    100.0 μl
  • [0054]
    The resulting mutant water-soluble PQQGDH library was transformed into E. coli and each colony formed was transferred to a microtiter plate. The colony was further replica-plated on a first plate containing 10 mM glucose and PMS-DCIP and a second plate containing 100 mM glucose and PMS-CDIP, and both were visually evaluated for the PQQGDH activity. A number of clones showing comparable PQQGDH activities in both plates were obtained.
  • [0055]
    One of these clones was randomly selected and analyzed for the nucleotide sequence to show that glutamate 277 had been changed to glycine.
  • EXAMPLE 2
  • [0056]
    Each colony obtained in Example 1 was transferred to a microtiter plate. The colony was replica-plated on a first plate containing 20 mM glucose and PMS-DCIP and a second plate containing 20 mM lactose and PMS-CDIP, and both were visually evaluated for the PQQGDH activity. A number of clones showing a greatly lower activity for lactose than glucose in both plates were obtained.
  • [0057]
    One of these clones was randomly selected and analyzed for the nucleotide sequence to show that asparagine 452 had been changed to aspartate.
  • EXAMPLE 3
  • [0000]
    Construction of modified PQQGDH genes:
  • [0058]
    Based on the structural gene of the PQQGDH derived from Acinetobacter calcoaceticus shown as SEQ ID NO: 2, the nucleotide sequence encoding glutamate 277 or isoleucine 278 was replaced by the nucleotide sequences encoding given amino acid residues by site-directed mutagenesis according to a standard method as shown in FIG. 2 using the plasmid pGB2. Table 2 shows the sequences of the synthetic oligonucleotide target primers used for mutagenesis. In Table 2, “E277A” means that glutamate 277 is replaced by aspartate, for example.
    TABLE 2
    E277A 5′- GAG GTT AAT TGC ATC GTC AGA G -3′
    E277N 5′- C AAT GAG GTT AAT GTT ATC GTC AGA GTT TG -3′
    E277K 5′- GAG GTT AAT ATC ATC GTC AGA G -3′
    E277D 5′- GAG GTT AAT TTT ATC GTC AGA G -3′
    E277H 5′- C AAT GAG GTT AAT GTG ATC GTC AGA GTT TG -3′
    E277Q 5′- GAG GTT AAT TTG ATC GTC AGA G -3′
    E277V 5′- C AAT GAG GTT AAT TAC ATC GTC AGA GTT TG -3′
    E277G 5′- GAG GTT AAT TCC ATC GTC AGA G -3′
    I278F 5′- C AAT GAG GTT GAA TTC ATC GTC AGA G -3′
    N279H 5′- GAC AAT GAG GTC AAT TTC ATC GTC AGA GTT -3′
  • [0059]
    A KpnI-HindIII fragment containing a part of the gene encoding the PQQGDH derived from Acinetobacter calcoaceticus was integrated into the vector plasmid pKF18k (Takara Shuzo Co., Ltd.) and used as a template. Fifty fmols of this template, 5 pmol of the selection primer attached to the Mutan™-Express Km Kit (Takara Shuzo Co., Ltd.) and 50 pmol of the phosphorylated target primer were mixed with the annealing buffer attached to the kit in an amount equivalent to 1/10 of the total volume (20 μl), and the mixture was heated at 100° C. for 3 minutes to denature the plasmid into a single strand. The selection primer serves for reversion of dual amber mutations on the kanamycin-resistance gene of pKF18k. The mixture was placed on ice for 5 minutes to anneal the primers. To this mixture were added 3 μl of the extension buffer attached to the kit, 1 μl of T4 DNA ligase, 1 l of T4 DNA polymerase and 5 μl of sterilized water to synthesize a complementary strand.
  • [0060]
    The synthetic strand was transformed into a DNA mismatch repair-deficient strain E. coli BMH71-18mutS and shake-cultured overnight to amplify the plasmid.
  • [0061]
    Then, the plasmid copies were extracted from the cultures and transformed into E. coli MV1184 and then extracted from the colonies. These plasmids were sequenced to confirm the introduction of the intended mutations. These fragments were substituted for the KpnI-HindIII fragment of the gene encoding the wild-type PQQGDH on the plasmid pGB2A to construct genes for modified PQQGDHs.
  • [0062]
    An oligonucleotide target primer of the sequence:
    • 5′-C ATC TTT TTG GAC ATG TCC GGC AGT AT-3′ was synthesized in the same manner to substitute histidine for asparagine 452. Site-directed mutagenesis was performed by the method shown in FIG. 2 using the plasmid pGB2. Genes for modified PQQGDHs carrying mutations Asp448Asn, Asn452Asp, Asn452His, Asn452Lys, Asn452Thr, Asn452Ile, Lys455Ile, Asp456Asn, Asp457Asn and Asn462Asp were also constructed.
    EXAMPLE 4 Preparation of Modified Enzymes
  • [0064]
    The gene encoding the wild-type or each modified PQQGDH was inserted into the multicloning site of an E. coli expression vector pTrc99A (Pharmacia), and the resulting plasmid was transformed into the E. coli strain DH5α. The transformant was shake-cultured at 37° C. overnight on 450 ml of L medium (containing 50 μg/ml of ampicillin) in a Sakaguchi flask, and inoculated on 7 l of L medium containing 1 mM CaCl2 and 500 μM PQQ. About 3 hours after starting cultivation, isopropyl thiogalactoside was added at a final concentration of 0.3 mM, and cultivation was further continued for 1.5 hours. The cultured cells were harvested from the medium by centrifugation (5,000× g, 10 min, 4° C.), and washed twice with a 0.85% NaCl solution. The collected cells were disrupted with a French press, and centrifuged (10,000× g, 15 min, 4° C.) to remove undisrupted cells. The supernatant was ultracentrifuged (160,500× g (40,000 r.p.m.), 90 min, 4° C.) to give a water-soluble fraction, which was used in the subsequent examples as a crude enzyme sample.
  • [0065]
    Thus obtained water-soluble fraction was further dialyzed against 10 mM phosphate buffer, pH 7.0 overnight. The dialyzed sample was adsorbed to a cation chromatographic column TSKgel CM-TOYOPEARL 650M (Tosoh Corp.), which had been equilibrated with 10 mM phosphate buffer, pH 7.0. This column was washed with 750 ml of 10 mM phosphate buffer, pH 7.0 and then the enzyme was eluted with 10 mM phosphate buffer, pH 7.0 containing 0-0.2 M NaCl at a flow rate of 5 ml/min. Fractions having GDH activity were collected and dialyzed against 10 mM MOPS-NAOH buffer, pH 7.0 overnight. Thus, an electrophoretically homogeneous modified PQQGDH protein was obtained. This was used in the subsequent examples as a purified enzyme sample.
  • EXAMPLE 5 Assay of Enzyme Activity
  • [0066]
    Enzyme activity was assayed by using PMS (phenazine methosulfate)-DCIP (2,6-dichlorophenolindophenol) in 10 mM MOPS-NaOH buffer (pH 7.0) to monitor changes in the absorbance of DCIP at 600 nm with a spectrophotometer and expressing the reaction rate of the enzyme as the rate of decrease in the absorbance. The enzyme activity for reducing 1 μmol of DCIP in 1 minute was 1 U. The molar extinction coefficient of DCIP at pH 7.0 was 16.3 mM−1.
  • EXAMPLE 6
  • [0000]
    Evaluation of Affinity of Crude Enzyme Samples for Glucose:
  • [0067]
    Each of the crude enzyme samples of the wild-type and modified PQQGDHs obtained in Example 4 was converted into a holoenzyme in the presence of 1 μM PQQ and 1 mM CaCl2 for 1 hour or longer. A 187 μl-aliquot was combined with 3 μl of an activating reagent (prepared from 48 μl of 6 mM DCIP, 8 μl of 600 mM PMS and 16 l of 10 mM phosphate buffer, pH 7.0) and 10 μl of D-glucose solutions at various concentrations, and assayed for the enzyme activity at room temperature by the method shown in Example 5. The Km was determined by plotting the substrate concentration vs. enzyme activity. The results are shown in Table 3.
    TABLE 3
    Km (mM)
    Wild type 26.0
    G277A 1.5
    G277N 1.2
    G277K 8.9
    G277D 7.4
    G277H 7.7
    G277Q 4.3
    G277V 2.5
    G277G 0.3
    I278F 7.0
    N279H 15.7
    N452T 12.5
    N462D 12.2
    N462K 11.0
    N462Y 20.4
  • [0068]
    The Km value of the wild-type PQQGDH for glucose reported to date was about 25 mM. In contrast, all the enzymes constructed here to carry mutations in glutamate 277 and Ile278Phe had a Km value for glucose of less than 10 mM. These results show that modified PQQGDHs of the present invention have high affinity for glucose.
  • EXAMPLE 7
  • [0000]
    Evaluation of Affinity of Purified Enzyme Samples for Glucose:
  • [0069]
    Each of the purified samples of the wild-type enzyme and the modified enzyme Glu277Lys obtained in Example 4 was converted into a holoenzyme in the presence of 1 μM PQQ and 1 mM CaCl2 for 1 hour or longer in the same manner as in Example 6. A 187 μl-aliquot was combined with 3 μl of an activating reagent (prepared from 48 l of 6 mM DCIP, 8 μl of 600 mM PMS and 16 μl of 10 mM phosphate buffer, pH 7.0) and 10 l of D-glucose solutions at various concentrations, and assayed for the enzyme activity at room temperature by the method shown in Example 5. The Km and Vmax were determined by plotting the substrate concentration vs. enzyme activity. The Glu277Lys variant had a Km value for glucose of about 8.8 mM and a Vmax value of 3668 U/mg. The Km value of the wild-type PQQGDH for glucose reported to date was about 25 mM with the Vmax value being 2500-7000 U/mg depending on the measurement conditions. These results show that the modified PQQGDH Glu277Lys is an enzyme having remarkably improved affinity for glucose and high activity comparable to that of the wild-type PQQGDH.
  • EXAMPLE 8
  • [0000]
    Evaluation of Substrate Specificity:
  • [0070]
    Crude samples of various modified enzymes were tested for substrate specificity. Each of the crude samples of the wild-type and various modified PQQGDHs was converted into a holoenzyme in the presence of 1 μM PQQ and 1 mM CaCl2 for 1 hour or longer. A 187 μl-aliquot was combined with 3 μl of an activating reagent (containing 6 mM DCIP, 600 mM PMS and 10 mM phosphate buffer, pH 7.0) and a substrate. The substrates tested were 400 mM glucose, lactose and maltose at a final concentration of 20 mM, and each sample was incubated with 10 l of each substrate at room temperature for 30 minutes and assayed for the enzyme activity in the same manner as in Example 5 to determine the relative activity expressed as the percentage of the activity for glucose. As shown in Table 4, all the modified enzymes of the present invention showed higher selectivity for glucose than that of the wild-type enzyme.
    TABLE 4
    Glucose Lactose Maltose
    Wild-type 100% 61% 61%
    Asp448Asn 100% 48% 36%
    Asn452Asp 100% 56% 50%
    Asn452His 100% 39% 39%
    Asn452Lys 100% 55% 42%
    Asn452Thr 100% 42% 30%
    Asn452Ile 100% 36% 28%
    Lys455Ile 100% 49% 37%
    Asp456Asn 100% 59% 41%
    Asp457Asn 100% 43% 32%
    Asn462Asp 100% 52% 41%
  • EXAMPLE 9
  • [0000]
    Glucose Assay:
  • [0071]
    Modified PQQGDHs were used for assaying glucose. Each of the modified enzymes Glu277Lys and Asn452Thr was converted into a holoenzyme in the presence of 1 μM PQQ and 1 mM CaCl2 for 1 hour or longer, and assayed for the enzyme activity in the presence of glucose at various concentrations as well as 5 μM PQQ and 10 mM CaCl2 by the method described in Example 5 based on changes of the absorbance of DCIP at 600 nm. As shown in FIG. 3, the modified PQQGDH Asn452Thr could be used for assaying glucose in the range of 0.1-20 mM. Similar results were obtained with the modified PQQGDH Glu277Lys.
  • EXAMPLE 10
  • [0000]
    Preparation and Evaluation of an Enzyme Sensor:
  • [0072]
    Five units each of the modified enzymes Glu277Lys and Asn452Thr were freeze-dried with 20 mg of carbon paste. After thorough mixing, the mixture was applied only on the surface of a carbon paste electrode preliminarily filled with about 40 mg of carbon paste and polished on a filter paper. This electrode was treated in 10 mM MOPS buffer (pH 7.0) containing 1% glutaraldehyde at room temperature for 30 minutes followed by 10 mM MOPS buffer (pH 7.0) containing 20 mM lysine at room temperature for 20 minutes to block glutaraldehyde. The electrode was equilibrated in 10 mM MOPS. buffer (pH 7.0) at room temperature for 1 hour or longer and then stored at 4° C.
  • [0073]
    Thus prepared enzyme sensor was used to measure glucose levels. The enzyme sensor having a modified PQQGDH of the present invention immobilized thereon can be used for assaying glucose in the range of 0.1 mM-5 mM.
  • INDUSTRIAL APPLICABILITY
  • [0074]
    Modified PQQGDHs of the present invention have high affinity for glucose so that they are expected to provide the advantages that assay kits or enzyme sensors prepared with such enzymes can measure glucose at lower levels with remarkably improved sensitivity as compared with conventional natural PQQGDHs.

Claims (22)

  1. 1. An isolated modified water-soluble glucose dehydrogenase having pyrroloquinoline quinone as a coenzyme characterized in that at least one amino acid residue in a natural water-soluble glucose dehydrogenase derived from Acinetobacter is replaced by another amino acid residue and it has improved affinity for glucose as compared with the natural water-soluble glucose dehydrogenase.
  2. 2. The isolated modified glucose dehydrogenase of claim 1 having high selectivity for glucose as compared with the wild-type PQQGDH of SEQ ID NO: 1.
  3. 3. An isolated modified glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein asparagine 462 (asparagine 438 of SEQ ID NO: 1) in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus or an amino acid residue corresponding to said residue is replaced by another amino acid residue.
  4. 4. An isolated modified glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein asparagine 452 (asparagine 428 of SEQ ID NO: 1) in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus or an amino acid residue corresponding to said residue is replaced by another amino acid residue.
  5. 5. An isolated modified glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein lysine 455 (lysine 431 of SEQ ID NO: 1) in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus or an amino acid residue corresponding to said residue is replaced by another amino acid residue.
  6. 6. An isolated modified glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein aspartate 456 (aspartate 432 of SEQ ID NO: 1) in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus or an amino acid residue corresponding to said residue is replaced by another amino acid residue.
  7. 7. An isolated modified glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein aspartate 457 (aspartate 433 of SEQ ID NO: 1) in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus or an amino acid residue corresponding to said residue is replaced by another amino acid residue.
  8. 8. An isolated modified glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein aspartate 448 (aspartate 424 of SEQ ID NO: 1) in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus or an amino acid residue corresponding to said residue is replaced by another amino acid residue.
  9. 9. An isolated modified glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein at least one amino acid residue is replaced by another amino acid residue in the region corresponding to residues 268-289 (244-265 of SEQ ID NO: 1) or 448-468 (424-434 of SEQ ID NO: 1) in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus.
  10. 10. An isolated modified water-soluble glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein glutamate 277 (glutamate 253 of SEQ ID NO: 1) in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus or an amino acid residue corresponding to said residue is replaced by another amino acid residue.
  11. 11. An isolated modified water-soluble glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyrne wherein isoleucine 278 (isoleucine 254 of SEQ ID NO: 1) in the water-soluble PQQGDH derived from Acinetobacter calcoaceticus or an amino acid residue corresponding to said residue is replaced by another amino acid residue.
  12. 12. An isolated modified water-soluble glucose dehydrogenase having pyrrolo-quinoline quinone as a coenzyme wherein at least one amino acid residue is replaced by another amino acid residue in the region defined by residues 268-289 (244-265 of SEQ ID NO: 1) or 448-468 (424-434 of SEQ ID NO: 1) in the amino acid sequence shown as SEQ ID NO: 1.
  13. 13. An isolated modified PQQ glucose dehydrogenase comprising the sequence (SEQ ID NO: 14):
    Xaa8 Thr Ala Gly Xaa1 Val Gln Xaa2 Xaa3 Xaa4 Gly Ser Val Thr Xaa5 Thr Leu Glu Asn Pro Gly
    wherein Xaa1, Xaa2, Xaa3, Xaa4, Xaa5 and Xaa8 represent any natural amino acid residue, provided that when Xaa1 represents Asn, Xaa2 represents Lys, Xaa3 represents Asp, Xaa4 represents Asp and Xaa5 represents Asn, then Xaa8 does not represent Asp.
  14. 14. An isolated modified PQQ glucose dehydrogenase comprising the sequence (SEQ ID NO: 3):
    Ser Glu Gln Gly Pro Asn Ser Asp Asp Xaa6 Xaa7 Asn Leu Ile Val Lys Gly Gly Asn TyrGlyTrp
    wherein Xaa6 and Xaa7 represent any natural amino acid residue, provided that when Xaa6 represents Glu, Xaa7 does not represent Ile.
  15. 15. The isolated modified glucose dehydrogenase of claim 14 wherein glutamate 277 (glutamate 253 of SEQ ID NO: 1) is replaced by another amino acid residue.
  16. 16. The isolated modified glucose dehydrogenase of claim 14 wherein isoleucine 278 (isoleucine 254 of SEQ ID NO: 1) is replaced by another amino acid residue.
  17. 17. A gene encoding the modified glucose dehydrogenase of claim 1.
  18. 18. A vector comprising the gene of claim 17.
  19. 19. A transformant comprising the gene of claim 17.
  20. 20. The transform ant of claim 19 wherein the gene of claim 17 is integrated into the main chromosome.
  21. 21. A glucose assay kit comprising the modified glucose dehydrogenase of claim 1.
  22. 22. A glucose sensor comprising the modified glucose dehydrogenase of claim
US11184834 1999-04-30 2005-07-20 Glucose dehydrogenase Abandoned US20060019328A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP12428599A JP2000312588A (en) 1999-04-30 1999-04-30 Glucose dehydrogenase
JP124285/1999 1999-04-30
JP2000009137A JP2001197888A (en) 2000-01-18 2000-01-18 Glucose dehydrogenase having excellent substrate specificity
JP9137/2000 2000-01-18
US09959549 US7049114B1 (en) 1999-04-30 2000-05-01 Glucose dehydrogenase
PCT/JP2000/002872 WO2000066744A1 (en) 1999-04-30 2000-05-01 Glucose dehydrogenase
US11184834 US20060019328A1 (en) 1999-04-30 2005-07-20 Glucose dehydrogenase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11184834 US20060019328A1 (en) 1999-04-30 2005-07-20 Glucose dehydrogenase

Publications (1)

Publication Number Publication Date
US20060019328A1 true true US20060019328A1 (en) 2006-01-26

Family

ID=26460990

Family Applications (2)

Application Number Title Priority Date Filing Date
US09959549 Expired - Fee Related US7049114B1 (en) 1999-04-30 2000-05-01 Glucose dehydrogenase
US11184834 Abandoned US20060019328A1 (en) 1999-04-30 2005-07-20 Glucose dehydrogenase

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09959549 Expired - Fee Related US7049114B1 (en) 1999-04-30 2000-05-01 Glucose dehydrogenase

Country Status (7)

Country Link
US (2) US7049114B1 (en)
EP (1) EP1176202B1 (en)
KR (1) KR20020010624A (en)
CN (1) CN100410379C (en)
CA (1) CA2372741A1 (en)
DE (2) DE60029775D1 (en)
WO (1) WO2000066744A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080206833A1 (en) * 2005-06-20 2008-08-28 Arkray, Inc. Mutant Glucose Dehydrogenase
US20090176262A1 (en) * 2002-12-24 2009-07-09 Hironori Omura Coenzyme-binding glucose dehydrogenase
US20110122870A1 (en) * 2009-11-23 2011-05-26 Cisco Technology, Inc. System and method for providing a sequence numbering mechanism in a network environment

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2372741A1 (en) * 1999-04-30 2000-11-09 Koji Sode Glucose dehydrogenase
EP1332216B1 (en) 2000-10-27 2011-08-17 Roche Diagnostics GmbH Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
USRE44522E1 (en) 2001-09-14 2013-10-08 Arkray, Inc. Concentration measuring method, concentration test instrument, and concentration measuring apparatus
USRE45764E1 (en) 2001-09-14 2015-10-20 Arkray, Inc. Concentration measuring method, concentration test instrument, and concentration measuring apparatus
CN1304838C (en) 2001-09-14 2007-03-14 爱科来株式会社 Concentration measuring method, concentration test instrument, and concentration measuring apparatus
JP2003093071A (en) * 2001-09-26 2003-04-02 Koji Hayade Glucose dehydrogenase
US7476525B2 (en) 2002-05-27 2009-01-13 Toyo Boseki Kabushiki Kaisha Modified pyrroloquinoline quinone (PQQ) dependent glucose dehydrogenase with superior substrate specificity and stability
WO2004005499A1 (en) * 2002-07-04 2004-01-15 Koji Sode Glucose dehydrogenase
EP1666586B1 (en) * 2003-09-08 2009-10-21 Toyo Boseki Kabushiki Kaisha Pyrroloquinoline quinone (pqq)-dependent glucose dehydrogenase modification having excellent substrate specificity
DE10320259A1 (en) * 2003-05-07 2004-11-25 Bayer Technology Services Gmbh Novel glucose dehydrogenase and their production
JP4639302B2 (en) 2004-04-23 2011-02-23 アークレイ株式会社 Mutant glucose dehydrogenase
JP4842938B2 (en) * 2004-07-20 2011-12-21 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Genetically engineered pyrroloquinoline quinone dependent glucose dehydrogenase comprising an amino acid insertion
CA2581226C (en) 2004-10-15 2011-06-14 Mara Boenitz-Dulat Thermostable mutants of pyrroloquinoline quinone dependent glucose dehydrogenase
JP5020070B2 (en) 2005-03-25 2012-09-05 池田食研株式会社 Polynucleotides encoding coenzyme-conjugated glucose dehydrogenase
US8492130B2 (en) 2006-06-29 2013-07-23 Ikeda Food Research Co., Ltd. FAD-conjugated glucose dehydrogenase gene
US8329439B2 (en) 2007-06-21 2012-12-11 Arkray, Inc. Glucose dehydrogenase
FR2948680B1 (en) * 2009-07-28 2013-10-04 Centre Nat Rech Scient New mutants of the PQQ s-gdh
CN105331591A (en) * 2015-10-29 2016-02-17 英科隆生物技术(杭州)有限公司 PQQ-sGDH mutant, polynucleotide and glucose detection device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103509A (en) * 1997-03-03 2000-08-15 Lifescan Inc. Modified glucose dehydrogenase
US20060099698A1 (en) * 1999-04-08 2006-05-11 Koji Sode Glucose dehydrogenases
US7049114B1 (en) * 1999-04-30 2006-05-23 Koji Sode Glucose dehydrogenase
US20070134750A2 (en) * 2002-07-04 2007-06-14 Koji Sode Glucose dehydrogenase

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103509A (en) * 1997-03-03 2000-08-15 Lifescan Inc. Modified glucose dehydrogenase
US20060099698A1 (en) * 1999-04-08 2006-05-11 Koji Sode Glucose dehydrogenases
US7049114B1 (en) * 1999-04-30 2006-05-23 Koji Sode Glucose dehydrogenase
US20070134750A2 (en) * 2002-07-04 2007-06-14 Koji Sode Glucose dehydrogenase

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090176262A1 (en) * 2002-12-24 2009-07-09 Hironori Omura Coenzyme-binding glucose dehydrogenase
US20080206833A1 (en) * 2005-06-20 2008-08-28 Arkray, Inc. Mutant Glucose Dehydrogenase
US7604969B2 (en) 2005-06-20 2009-10-20 Arkray, Inc. Mutant glucose dehydrogenase
US7776575B2 (en) 2005-06-20 2010-08-17 Arkray, Inc. Mutant glucose dehydrogenase
US20110122870A1 (en) * 2009-11-23 2011-05-26 Cisco Technology, Inc. System and method for providing a sequence numbering mechanism in a network environment

Also Published As

Publication number Publication date Type
EP1176202A4 (en) 2002-10-30 application
DE60029775D1 (en) 2006-09-14 grant
EP1176202B1 (en) 2006-08-02 grant
US7049114B1 (en) 2006-05-23 grant
EP1176202A1 (en) 2002-01-30 application
WO2000066744A1 (en) 2000-11-09 application
CN1353759A (en) 2002-06-12 application
CN100410379C (en) 2008-08-13 grant
DE60029775T2 (en) 2007-08-02 grant
KR20020010624A (en) 2002-02-04 application
CA2372741A1 (en) 2000-11-09 application

Similar Documents

Publication Publication Date Title
Chen et al. Site-specific mutagenesis of Drosophila alcohol dehydrogenase: evidence for involvement of tyrosine-152 and lysine-156 in catalysis
Matsushita et al. Quinoproteins: structure, function, and biotechnological applications
WO2010140431A1 (en) Flavin-bound glucose dehydrogenase
US7115403B1 (en) Directed evolution of galactose oxidase enzymes
JP2008237210A (en) Modified flavin adenine dinucleotide-dependent glucose dehydrogenase
US20130309750A1 (en) E. coli transformant, method for producing flavin-bound glucose dehydrogenase using the same, and mutant flavin-bound glucose dehydrogenases
US6103509A (en) Modified glucose dehydrogenase
WO2002034919A1 (en) Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
EP1367120A2 (en) Modified pyrroloquinoline quinone (PQQ) dependent glucose dehydrogenase with superior substrate specificity and stability
EP1862543A1 (en) Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same
WO2009084616A1 (en) Modified glucose dehydrogenase gene
Cozier et al. Characterization of the membrane quinoprotein glucose dehydrogenase from Escherichia coli and characterization of a site-directed mutant in which histidine-262 has been changed to tyrosine.
JP2001346587A (en) Glucose dehydrogenase excellent in substrate specificity
Igarashi et al. Construction and characterization of mutant water-soluble PQQ glucose dehydrogenases with altered Km values—site-directed mutagenesis studies on the putative active site
Matsushita et al. Soluble and membrane-bound quinoprotein D-glucose dehydrogenases of the Acinetobacter calcoaceticus: the binding process of PQQ to the apoenzymes
US20050067278A1 (en) Oxygen electrode
WO2012001976A1 (en) Glucose dehydrogenase
EP1167519A1 (en) Glucose dehydrogenase
JP2010057427A (en) Glucose dehydrogenase and method for electrochemical measurement of glucose
JP2001197888A (en) Glucose dehydrogenase having excellent substrate specificity
JP2001037483A (en) Linked glucose dehydrogenase
EP1176202A1 (en) Glucose dehydrogenase
JP2000312588A (en) Glucose dehydrogenase
EP1739174A1 (en) Mutated glucose dehydrogenase
EP2020439A1 (en) Eukaryotic amadoriase having excellent thermal stability, gene and recombinant dna for the eukaryotic amadoriase, and process for production of eukaryotic amadoriase having excellent thermal stability

Legal Events

Date Code Title Description
AS Assignment

Owner name: ULTIZYME INTERNATIONAL LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SODE, KOJI;REEL/FRAME:018990/0104

Effective date: 20061213